To apply for the Asston Pharmaceuticals IPO, investors need to log in to their trading account through a registered brokerage platform that supports IPO applications. Navigate to the IPO section and select “Asston Pharmaceuticals IPO” from the active listings. Choose the number of lots (minimum lot size is 1,000 shares) and enter a bid price within the price band of ₹115 to ₹123 per share. Provide a valid UPI ID for payment and authorise the mandate in your UPI app before 5 PM on July 11, 2025. Once submitted and approved, you will receive a confirmation of your application.
For complete details on this public offering, visit the Asston Pharmaceuticals IPO page on Bajaj Broking’s website.
Asston Pharmaceuticals IPO Application Process
The Asston Pharmaceuticals IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Step 1: Login to Your Trading Platform
Access your trading account using Bajaj Broking’s app or website.
Step 2: Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Step 3: Select the Open IPO and Click Apply
Locate Asston Pharmaceuticals IPO in the list of available IPOs and click the ‘Apply’ button.
Step 4: Enter the Quantity of Shares You Wish to Apply For
Specify the number of shares (minimum lot size: 1000 shares) within the price band of ₹115 to ₹123 per share.
Step 5: Provide Your UPI ID
Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.
Step 6: Confirm the Application
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Step 7: Complete the Process and Wait for Allotment
Submit the application and monitor the allotment status to check if shares have been allocated to you.
Additional Read: Asston Pharmaceuticals IPO Investment Guide: Objectives & Opportunities
About Asston Pharmaceuticals IPO: Overview and Key Facts
The upcoming Asston Pharmaceuticals IPO is scheduled to open on July 9, 2025, and close on July 11, 2025. It comprises 22,41,000 equity shares, with an overall issue size of up to ₹27.56 crore. The shares are priced between ₹115 and ₹123, with a minimum investment requirement set at 1,000 shares per lot. Applications can be made through registered brokers’ IPO platforms, where investors will need to select the lot size, specify their bid price within the band, and provide a valid UPI ID for payment authorization. The UPI mandate must be approved before 5 PM on the closing day to ensure application processing.
Following the IPO, the tentative allotment of shares is scheduled for July 14, 2025, with refunds initiated and demat credits expected by July 15, 2025. The IPO is slated for listing on BSE SME, with JSK Securities and Services Pvt. Ltd. appointed as the market maker. Maashitla Securities Pvt. Ltd. is acting as the registrar, while Sobhagya Capital Options Ltd. serves as one of the lead managers for the issue.
The objective of the IPO is primarily to facilitate an offer for sale and secure the benefits associated with being a listed entity. Offering shares on the exchange may enhance the company’s visibility and provide a mechanism for existing shareholders to realise their stakes. The listing may also support the firm's ongoing focus on manufacturing and exporting a broad range of pharmaceutical and nutraceutical products to various Asian and African markets.
To check your application status, visit the Asston Pharmaceuticals IPO Allotment Status page on Bajaj Broking’s website.